跳至主要内容
临床试验/KCT0008319
KCT0008319招募中Unknown

Efficacy and Safety of Clopidogrel for primary prevention in patients with subclinical coronary atherosclerosis identified on imaging

Seoul National University Hospital0 个研究点目标入组 9,930 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
9,930

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40(Year) 至 o Limit(—)
性别
All

入选标准

  • 1.Male and female aged =40 years
  • 2.Patients with subclinical coronary atherosclerosis identified from coronary CT angiography or coronary angiography within 2 years without clinical events after an imaging study
  • 3.Without significant coronary artery stenosis (Diameter stenosis >50%), which needs revascularization
  • 4.Agreement to give written informed consent

排除标准

  • 1.A history of a diagnosed cardiovascular event (myocardial infarction, heart failure, peripheral artery disease, stroke, transient ischemic attack, carotid artery stenosis>50%, carotid artery intervention)
  • 2.A history of coronary artery intervention or coronary artery bypass graft surgery, which needs chronic maintenance of antiplatelet therapy
  • 3.Absolute contraindication or allergy to clopidogrel
  • 4.Patients receiving anticoagulants for other comorbidities
  • 5.A history of Bleeding diathesis, known coagulopathy, major bleeding, BARC class =3, resulting in the stop of antiplatelet agents
  • 6Planned surgery or intervention which needs to stop antiplatelet agents =1 month
  • 7.Presence of non-cardiac comorbidity with life expectancy = 5 years from randomization
  • 8.Females with childbearing potential or breast-feeding
  • 9.Patients who are thought to be inappropriate for the trial based on physicians’ discretion

研究者

相似试验

招募中
4 期
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)Coronary Artery Disease
NCT05845489Seoul National University Hospital11,086
进行中(未招募)
1 期
Is intensive blood thinning with three antiplatelet drugs better than the current guideline treatment in reducing recurrence after acute stroke?
EUCTR2007-006749-42-DKniversity of Nottingham4,100
进行中(未招募)
1 期
Is intensive blood thinning with three antiplatelet drugs better than the current guideline treatment in reducing recurrence after acute stroke?Ischaemic stroke and TIA (transient ischaemic attack)MedDRA version: 14.1 Level: LLT Classification code 10042244 Term: Stroke System Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.1 Level: PT Classification code 10044390 Term: Transient ischaemic attack System Organ Class: 10029205 - Nervous system disorders
EUCTR2007-006749-42-GBniversity of Nottingham3,096
已完成
2 期
The effect of clopidogrel in prevention of access graft thrombosis in upper extremity.Chronic Renal Failure -Hemodialysis.Chronic Renal Failure -Dialysis
IRCT2013012412256N1Kermanshah Univesity of Medical sciences50
进行中(未招募)
不适用
Effectiveness of Prasugrel versus Clopidogrel in Subjects with High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention with Implantation of Drug-Eluting Stent - TACWReduction of composite cardio-vascular end-point in patients who have successfully undergone elective percutaneous coronary intervention with placement of at least one drug-eluting stent.
EUCTR2008-004997-41-DEEli Lilly and Company3,250